IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 4,135.00
-110.00 (-2.59%)
Jun 10, 2026, 3:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 57.96 billion as of June 10, 2026. Its market cap has decreased by -53.28% in one year.
Market Cap
57.96B
Enterprise Value
39.00B
Revenue
5.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,135.00
Market Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 57.96B, a decrease of -88.49%. That is a compound annual growth rate of -62.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 59.51B | -57.08% |
| Dec 30, 2025 | 138.64B | -7.14% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Macrogen | 124.57B |
| Vaxcell-Bio Therapeutics | 119.08B |
| MedPacto | 118.76B |
| Amicogen | 99.20B |
| GeneOne Life Science | 98.38B |
| ENCell | 90.21B |
| iNtRON Biotechnology | 82.67B |
| Prestige BioPharma | 81.61B |